首页> 美国卫生研究院文献>PLoS Clinical Trials >Deep RNA Sequencing Reveals Novel Cardiac Transcriptomic Signatures for Physiological and Pathological Hypertrophy
【2h】

Deep RNA Sequencing Reveals Novel Cardiac Transcriptomic Signatures for Physiological and Pathological Hypertrophy

机译:深度RNA测序揭示了生理性和病理性肥大的新型心脏转录组特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although both physiological hypertrophy (PHH) and pathological hypertrophy (PAH) of the heart have similar morphological appearances, only PAH leads to fatal heart failure. In the present study, we used RNA sequencing (RNA-Seq) to determine the transcriptomic signatures for both PHH and PAH. Approximately 13–20 million reads were obtained for both models, among which PAH showed more differentially expressed genes (DEGs) (2,041) than PHH (245). The expression of 417 genes was barely detectable in the normal heart but was suddenly activated in PAH. Among them, Foxm1 and Plk1 are of particular interest, since Ingenuity Pathway Analysis (IPA) using DEGs and upstream motif analysis showed that they are essential hub proteins that regulate the expression of downstream proteins associated with PAH. Meanwhile, 52 genes related to collagen, chemokines, and actin showed opposite expression patterns between PHH and PAH. MAZ-binding motifs were enriched in the upstream region of the participating genes. Alternative splicing (AS) of exon variants was also examined using RNA-Seq data for PAH and PHH. We found 317 and 196 exon inclusions and exon exclusions, respectively, for PAH, and 242 and 172 exon inclusions and exclusions, respectively for PHH. The AS pattern was mostly related to gains or losses of domains, changes in activity, and localization of the encoded proteins. The splicing variants of 8 genes (i.e., Fhl1, Rcan1, Ndrg2, Synpo, Ttll1, Cxxc5, Egfl7, and Tmpo) were experimentally confirmed. Multilateral pathway analysis showed that the patterns of quantitative (DEG) and qualitative (AS) changes differ depending on the type of pathway in PAH and PHH. One of the most significant changes in PHH is the severe downregulation of autoimmune pathways accompanied by significant AS. These findings revealed the unique transcriptomic signatures of PAH and PHH and also provided a more comprehensive understanding at both the quantitative and qualitative levels.
机译:尽管心脏的生理性肥大(PHH)和病理性肥大(PAH)都有相似的形态学表现,但只有PAH会导致致命的心力衰竭。在本研究中,我们使用RNA测序(RNA-Seq)来确定PHH和PAH的转录组特征。两种模型均获得约13–20百万条读数,其中PAH的差异表达基因(DEG)(2,041)比PHH(245)更多。在正常心脏中几乎检测不到417个基因的表达,但在PAH中突然被激活。其中,Foxm1和Plk1特别受关注,因为使用DEG进行的机能途径分析(IPA)和上游基序分析表明,它们是调节与PAH相关的下游蛋白表达的必不可少的枢纽蛋白。同时,与胶原,趋化因子和肌动蛋白有关的52个基因在PHH和PAH之间显示相反的表达模式。 MAZ结合基序丰富了参与基因的上游区域。还使用PAH和PHH的RNA-Seq数据检查了外显子变体的可变剪接(AS)。我们发现PAH分别有317和196个外显子包含和外显子排斥,PHH分别有242和172个外显子包含和排斥。 AS模式主要与域的获得或丧失,活性的变化和编码蛋白的定位有关。实验证实了8个基因(即Fhl1,Rcan1,Ndrg2,Synpo,Ttll1,Cxxc5,Egfl7和Tmpo)的剪接变体。多边途径分析表明,定量(DEG)和质量(AS)变化的模式因PAH和PHH中途径的类型而异。 PHH的最显着变化之一是自身免疫途径的严重下调并伴有大量AS。这些发现揭示了PAH和PHH的独特转录组特征,并且在定量和定性水平上也提供了更全面的理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号